ZBH

SEC source: 0000911916-17-000125 · edgar.xml · derivative · entry 1

Johnson Adam Rudolph · CIK 0001557600 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,440

Underlying: Common Stock · 17,440 shares

Expires 2027-03-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 21, 2018.

SEC source: 0000911916-17-000123 · edgar.xml · derivative · entry 1

Florin Daniel P · CIK 0001402459 · Sr. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,638

Underlying: Common Stock · 42,638 shares

Expires 2027-03-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 21, 2018.

SEC source: 0000911916-17-000121 · edgar.xml · derivative · entry 1

DVORAK DAVID C · CIK 0001239000 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,350

Underlying: Common Stock · 145,350 shares

Expires 2027-03-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 21, 2018.

SEC source: 0000911916-17-000119 · edgar.xml · derivative · entry 1

Delp Robert D. · CIK 0001696948 · President, Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,535

Underlying: Common Stock · 14,535 shares

Expires 2027-03-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 21, 2018.

SEC source: 0000911916-17-000115 · edgar.xml · nonDerivative · entry 3

DVORAK DAVID C · CIK 0001239000 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,886

F2 · shares: Securities sold to cover additional taxes on the vesting of restricted stock units pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.

F3 · price: Represents the sale of 1,040 shares in multiple transactions, ranging in price from $121.55 to $121.69 per share, resulting in a weighted average sale price of $121.627. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.

SEC source: 0000911916-17-000116 · edgar.xml · derivative · entry 3

Collins Tony W. · CIK 0001636683 · VP, Controller and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 878 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: The earned RSUs vested on March 17, 2017.

F4 · derivative.expiration_date: The earned RSUs vested on March 17, 2017.

SEC source: 0000911916-17-000116 · edgar.xml · nonDerivative · entry 2

Collins Tony W. · CIK 0001636683 · VP, Controller and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 924

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units.

SEC source: 0000911916-17-000116 · edgar.xml · nonDerivative · entry 1

Collins Tony W. · CIK 0001636683 · VP, Controller and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,205

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 109 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between October 31, 2016 and January 30, 2017.

SEC source: 0000911916-17-000115 · edgar.xml · derivative · entry 4

DVORAK DAVID C · CIK 0001239000 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,929 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F5 · derivative.exercise_date: The earned RSUs vested on March 17, 2017.

F5 · derivative.expiration_date: The earned RSUs vested on March 17, 2017.

SEC source: 0000911916-17-000115 · edgar.xml · nonDerivative · entry 2

DVORAK DAVID C · CIK 0001239000 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,926

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units.

SEC source: 0000911916-17-000115 · edgar.xml · nonDerivative · entry 1

DVORAK DAVID C · CIK 0001239000 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,077

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-17-000114 · edgar.xml · derivative · entry 2

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,685 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: The earned RSUs vested on March 17, 2017.

F2 · derivative.expiration_date: The earned RSUs vested on March 17, 2017.

SEC source: 0000911916-17-000114 · edgar.xml · nonDerivative · entry 1

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-17-000113 · edgar.xml · derivative · entry 3

Nolan David A. Jr. · CIK 0001635757 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,497 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: The earned RSUs vested on March 17, 2017.

F4 · derivative.expiration_date: The earned RSUs vested on March 17, 2017.

SEC source: 0000911916-17-000113 · edgar.xml · nonDerivative · entry 2

Nolan David A. Jr. · CIK 0001635757 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,102

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units.

SEC source: 0000911916-17-000113 · edgar.xml · nonDerivative · entry 1

Nolan David A. Jr. · CIK 0001635757 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,582

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 80 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between December 30, 2016 and January 30, 2017, 5 shares purchased on January 27, 2017 under the dividend reinvestment plan for the Company's common stock, and 11 shares acquired between November 1, 2016 and January 30, 2017 through dividend reinvestment in Mr. Nolan's IRA.

SEC source: 0000911916-17-000112 · edgar.xml · derivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,587 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: The earned RSUs vested on March 17, 2017.

F3 · derivative.expiration_date: The earned RSUs vested on March 17, 2017.

SEC source: 0000911916-17-000112 · edgar.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,424

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units.

SEC source: 0000911916-17-000112 · edgar.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,349

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-17-000111 · edgar.xml · derivative · entry 2

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,197 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: The earned RSUs vested on March 17, 2017.

F3 · derivative.expiration_date: The earned RSUs vested on March 17, 2017.

SEC source: 0000911916-17-000111 · edgar.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 244 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between May 2, 2016 and January 30, 2017 and 8 shares purchased between October 28, 2016 and January 27, 2017 under the dividend reinvestment plan for the Company's common stock.

SEC source: 0000911916-17-000062 · edgar.xml · derivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,197

Underlying: Common Stock · 1,197 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 1,197 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 17, 2017.

F3 · derivative.expiration_date: Earned RSUs will vest on March 17, 2017.

F2 · derivative.underlying_shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 1,197 RSUs.

F2 · balance_after: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 1,197 RSUs.

SEC source: 0000911916-17-000060 · edgar.xml · derivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,587

Underlying: Common Stock · 4,587 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 4,587 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 17, 2017.

F3 · derivative.expiration_date: Earned RSUs will vest on March 17, 2017.

F2 · derivative.underlying_shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 4,587 RSUs.

F2 · balance_after: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 4,587 RSUs.

SEC source: 0000911916-17-000058 · edgar.xml · derivative · entry 1

Nolan David A. Jr. · CIK 0001635757 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,497

Underlying: Common Stock · 1,497 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 1,497 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 17, 2017.

F3 · derivative.expiration_date: Earned RSUs will vest on March 17, 2017.

F2 · derivative.underlying_shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 1,497 RSUs.

F2 · balance_after: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 1,497 RSUs.

SEC source: 0000911916-17-000054 · edgar.xml · derivative · entry 1

DVORAK DAVID C · CIK 0001239000 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,929

Underlying: Common Stock · 23,929 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 23,929 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 17, 2017.

F3 · derivative.expiration_date: Earned RSUs will vest on March 17, 2017.

F2 · derivative.underlying_shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 23,929 RSUs.

F2 · balance_after: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 23,929 RSUs.

SEC source: 0000911916-17-000056 · edgar.xml · derivative · entry 1

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,685

Underlying: Common Stock · 4,685 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 4,685 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 17, 2017.

F3 · derivative.expiration_date: Earned RSUs will vest on March 17, 2017.

F2 · derivative.underlying_shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 4,685 RSUs.

F2 · balance_after: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 4,685 RSUs.

SEC source: 0000911916-17-000052 · edgar.xml · derivative · entry 1

Collins Tony W. · CIK 0001636683 · VP, Controller and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 878

Underlying: Common Stock · 878 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 878 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 17, 2017.

F3 · derivative.expiration_date: Earned RSUs will vest on March 17, 2017.

F2 · derivative.underlying_shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 878 RSUs.

F2 · balance_after: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 878 RSUs.

SEC source: 0000911916-17-000044 · edgar.xml · derivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,500 shares

Expires 2017-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on February 6, 2008.

SEC source: 0000911916-17-000044 · edgar.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,762

F1 · shares: Securities acquired or sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Phipps on August 16, 2016.

F3 · price: Represents the sale of 10,500 shares in multiple transactions, ranging in price from $117.32 to $117.90 per share, resulting in a weighted average sale price of $117.6172. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.

SEC source: 0000911916-17-000044 · edgar.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Securities acquired or sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Phipps on August 16, 2016.

F2 · balance_after: Includes 169 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between May 2, 2016 and January 30, 2017 and 249 shares purchased between April 29, 2016 and January 27, 2017 under the dividend reinvestment plan for the Company's common stock.

SEC source: 0000911916-17-000042 · edgar.xml · derivative · entry 9

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,962

Underlying: Common Stock · 12,963 shares

Expires 2024-03-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 17, 2015.

SEC source: 0000911916-17-000042 · edgar.xml · derivative · entry 8

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,765

Underlying: Common Stock · 17,530 shares

Expires 2023-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 8,765 of the options vested on each of March 18, 2014, 2015 and 2016; the remaining 8,765 of the options are scheduled to vest on March 18, 2017.

SEC source: 0000911916-17-000042 · edgar.xml · derivative · entry 7

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,312 shares

Expires 2022-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 5,657 of the options vested on March 19, 2013 and 5,656 of the options vested on each of March 19, 2014, 2015, and 2016.

SEC source: 0000911916-17-000042 · edgar.xml · derivative · entry 6

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,390 shares

Expires 2021-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 2,390 options vested on each of March 16, 2012, 2013, 2014, and 2015.

SEC source: 0000911916-17-000042 · edgar.xml · nonDerivative · entry 5

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,997

SEC source: 0000911916-17-000042 · edgar.xml · nonDerivative · entry 4

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-17-000042 · edgar.xml · nonDerivative · entry 3

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,229

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-17-000042 · edgar.xml · nonDerivative · entry 2

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,699

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-17-000042 · edgar.xml · nonDerivative · entry 1

Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,387

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-17-000040 · edgar.xml · derivative · entry 3

DVORAK DAVID C · CIK 0001239000 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,500 shares

Expires 2017-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on February 6, 2008.

SEC source: 0000911916-17-000040 · edgar.xml · nonDerivative · entry 2

DVORAK DAVID C · CIK 0001239000 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,148

F3 · shares: Securities sold to cover option exercise cost, taxes and fess pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.

F4 · price: Represents the sale of 43,207 shares in multiple transactions, ranging in price from $117.26 to $118.23 per share, resulting in a weighted average sale price of $117.7717. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.

SEC source: 0000911916-17-000040 · edgar.xml · nonDerivative · entry 1

DVORAK DAVID C · CIK 0001239000 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,355

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Securities acquired pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.

F2 · balance_after: Includes 269 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 2, 2016 and January 30, 2017.

SEC source: 0000911916-17-000016 · edgar.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,045.605

Underlying: Common Stock · 229.713 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 114.856 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: 114.856 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 3.201 phantom stock units accrued on October 28, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-17-000012 · edgar.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,832.395

Underlying: Common Stock · 258.729 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 28.170 phantom stock units accrued on October 28, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-17-000018 · edgar.xml · derivative · entry 1

Rhodes Jeffrey K. · CIK 0001560940 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,273.759

Underlying: Common Stock · 114.856 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 2.092 phantom stock units accrued on October 28, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-17-000014 · edgar.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,436.091

Underlying: Common Stock · 258.729 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 37.197 phantom stock units accrued on October 28, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-17-000010 · edgar.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,966.348

Underlying: Common Stock · 229.713 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 114.856 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: 114.856 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 5.006 phantom stock units accrued on October 28, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-17-000008 · edgar.xml · derivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,031.654

Underlying: Common Stock · 229.713 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 11.016 phantom stock units accrued on October 28, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-17-000006 · edgar.xml · derivative · entry 1

BISARO PAUL · CIK 0001237253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,991.63

Underlying: Common Stock · 114.856 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 5.461 phantom stock units accrued on October 28, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-17-000004 · edgar.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,528.14

Underlying: Common Stock · 258.729 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 13.848 phantom stock units accrued on October 28, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.